Gene: RNF20
Official Full Name: ring finger protein 20provided by HGNC
Gene Summary: The protein encoded by this gene shares similarity with BRE1 of S. cerevisiae. The protein encoded by this human gene is an E3 ubiquitin ligase that regulates chromosome structure by monoubiquitinating histone H2B. This protein acts as a putative tumor suppressor and positively regulates the p53 tumor suppressor as well as numerous histone H2A and H2B genes. In contrast, this protein also suppresses the expression of several protooncogenes and growth-related genes, including many genes that are induced by epidermal growth factor. This gene selectively suppresses the expression of some genes by interfering with chromatin recruitment of transcription elongation factor SII (TFIIS). [provided by RefSeq, Feb 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01454 | RNF20 Knockout cell line(ZR75-1) | Human | RNF20 | Negative | Online Inquiry |
RNF20 Gene Knockout Cell Lines are genetically engineered cells specifically designed to lack the RNF20 gene, which is crucial for maintaining proper chromatin structure and regulating gene expression through the ubiquitination process. By utilizing CRISPR-Cas9 technology, these cell lines enable researchers to investigate the diverse biological roles of RNF20 in cellular processes such as proliferation, differentiation, and response to environmental stressors. The complete KO of the RNF20 gene provides a powerful tool to study its impact on various signaling pathways and epigenetic modifications, thus facilitating the understanding of its contribution to diseases, including cancer and other genetic disorders.
The primary function of RNF20 involves serving as an E3 ubiquitin ligase that tags proteins for degradation, modulating gene transcription, and maintaining genome stability. Through loss-of-function studies using these knockout cell lines, researchers can elucidate the mechanistic pathways affected by the absence of RNF20, contributing to invaluable insights into cell cycle regulation, DNA repair mechanisms, and the development of tumorigenesis. The ability to delve deeper into the RNF20’s multifaceted roles can significantly enhance both fundamental research and translational applications in therapeutic interventions.
Compared to traditional gene silencing methods like RNA interference, RNF20 Gene Knockout Cell Lines offer several advantages, including the permanence of the knockout effect and the ability to study phenotypic changes across various generations of cells. This stability allows researchers to conduct long-term studies on the effects of RNF20 loss in a controlled setting, which is critical for exploring chronic conditions and the biological underpinnings of diseases.
The value of RNF20 Gene Knockout Cell Lines for researchers and clinicians lies in their contribution to advancing our understanding of gene function and regulation. These cell lines can facilitate downstream applications such as drug screening, genetic pathway elucidation, and personalized medicine initiatives, making them an essential resource in contemporary biomedical research. Our company specializes in providing high-quality and rigorously validated biological products, ensuring that you receive unparalleled reliability and support in your research endeavors. With our expertise, you can trust that you are equipped with the best tools for your scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.